Circulatory microRNAs as potential biomarkers for fatty liver disease: the Rotterdam study.
Xiaofang ZhangMichelle M J MensYasir J AbozaidDaniel BosSarwa Darwish MuradRobert J de KnegtM Arfan IkramMaikel P PeppelenboschMohsen GhanbariPublished in: Alimentary pharmacology & therapeutics (2020)
Plasma levels of several miRNAs can be used as biomarkers of FLD, laying the groundwork for future clinical applications.